What are the harmful side effects of pirfenidone?

Pirfenidone is an anti-fibrotic drug mainly used to treat idiopathic pulmonary fibrosis (IPF). The drug slows down the progression of pulmonary fibrosis and prolongs the survival of patients by inhibiting the activity of pro-fibrotic factors such as TGF-β. Although its efficacy is widely recognized, pirfenidone may still cause a series of side effects during long-term medication, some of which are harmful to the body. Therefore, close attention and timely treatment are required during treatment.

First of all, the most common side effects are gastrointestinal reactions, which often affect the patient's quality of daily life. Specific symptoms include loss of appetite, nausea, vomiting, diarrhea or abdominal discomfort. Some patients experience mild gastric bloating or loss of appetite in the early stages of taking the medication. If not taken seriously, it may lead to insufficient nutritional intake, weight loss, and even affect immunity. Long-term severe gastrointestinal discomfort may also lead to electrolyte imbalance, especially in elderly or frail patients. Therefore, doctors usually recommend that patients take medication after meals to reduce gastrointestinal irritation, appropriately adjust their diet, and, if necessary, add medications to protect the gastric mucosa.

Secondly, skin adverse reactions are also more prominent, especially photosensitivity reactions related to sunlight. If some patients are exposed to strong sunlight during pirfenidone treatment, their skin may develop erythema, itching, peeling, or even symptoms similar to sunburn, which is medically known as "phototoxic reaction." This is because pirfenidone is photosensitive and the drug accumulates in the body and reacts with ultraviolet light, causing skin damage. Once this happens, it will not only affect the appearance, but may also cause secondary infection. Therefore, doctors usually advise patients to avoid sun exposure while taking it, and to use sunscreen, hats or sun-protective clothing when going out to reduce the incidence of photosensitivity reactions.

Third, abnormal liver function is another concerning side effect of pirfenidone. Clinical studies have shown that some patients experience an increase in transaminases (ALT, AST) after taking this drug, suggesting possible liver cell damage. This injury is mostly mild to moderate, but without intervention, individual patients may develop drug-induced hepatitis. In particular, people with underlying liver disease (such as hepatitis B or fatty liver disease) are at higher risk. Therefore, liver function must be checked regularly during medication. Once an abnormal increase in transaminase levels is found, the dose must be adjusted promptly or the medication must be discontinued, and hepatoprotective treatment must be supplemented.

In addition, neurological side effects have also been reported, such as fatigue, dizziness, drowsiness, or decreased concentration. These symptoms often appear in the early stages of taking the medicine, and some patients will have symptoms that will lessen on their own after a period of adaptation. However, there may be safety hazards for people who are engaged in driving, operating machinery, etc. Therefore, when first starting to use pirfenidone, it is best to avoid high-risk operations until the body adapts. If neurological symptoms persist or worsen, you should seek medical advice promptly to evaluate whether it is related to the drug and consider adjusting the treatment plan.

In summary, pirfenidone has clear efficacy in the treatment of idiopathic pulmonary fibrosis, but the negative impact of its potential side effects on the body cannot be ignored. Gastrointestinal discomfort, photosensitivity reactions, liver function abnormalities, and neurological symptoms may affect patients' quality of life or even endanger their health. Therefore, when using this drug, you should strictly follow the doctor's instructions, conduct relevant examinations regularly, and maintain good communication with the doctor, so that if adverse reactions occur, they can be discovered as early as possible and dealt with appropriately, so as to achieve a balance between therapeutic effect and safety.

Reference materials:https://www.esbriet.com/